Drug-drug interaction between the direct-acting antiviral regimen of ombitasvir-paritaprevir-ritonavir plus dasabuvir and the HIV antiretroviral agent dolutegravir or abacavir plus lamivudine | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Drug-drug interaction between the direct-acting antiviral regimen of ombitasvir-paritaprevir-ritonavir plus dasabuvir and the HIV antiretroviral agent dolutegravir or abacavir plus lamivudine

Khatri A, Trinh R, Zhao W, Podsadecki T, Menon RM. Drug-drug interaction between the direct-acting antiviral regimen of ombitasvir-paritaprevir-ritonavir plus dasabuvir and the HIV antiretroviral agent dolutegravir or abacavir plus lamivudine. Antimicrob Agents Chemother. 2016;60(10):6244-6251.

Publication Type:

Journal Article

Authors:

Khatri, A.; Trinh, R.; Zhao, W.; Podsadecki, T.; Menon, Rajeev M.

Source:

Antimicrob Agents Chemother, Volume 60, Issue 10, p.6244-6251 (2016)

Keywords:

abacavir, lamivudine

Notes:

Washington, DC

Cited On:

Export Citation:

RIS Format

Top